FBRX

Forte Biosciences Inc. (FBRX) is a clinical-stage biopharmaceutical company based in Torrance, California, dedicated to developing innovative therapeutics for skin diseases, particularly eczema and related conditions. Utilizing a proprietary platform backed by advanced genetic and biological research, the company aims to deliver targeted treatment solutions that enhance patient outcomes in dermatology. As Forte progresses through key clinical trials and regulatory hurdles, it is poised to establish a significant presence in the dermatological therapy market, offering attractive investment opportunities for institutional investors in the biotechnology sector.